SAN DIEGO, Oct. 20, 2015 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ:RTRX) today announced it will report third quarter 2015 financial results on Tuesday, November 3, 2015 after the close of the U.S. financial markets. The Company will host a conference call and webcast to review the financial and operational results and provide a general business update at 4:30 p.m. ET.
|Conference Call Information|
|Date:||Tuesday, November 3, 2015|
|Time:||4:30 p.m. ET|
|Dial-in numbers:||+1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International)|
|Live webcast:||www.retrophin.com in the “Events & Presentations” section of the “Investors” page|
A replay of the call will be available 7:30 p.m. ET, November 3, 2015 to 11:59 p.m., November 10, 2015. The replay number is 855-859-2056 (U.S.) or 404-537-3406 (International), confirmation code 65067721.
Retrophin is a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases for which there are currently no viable options for patients. The Company's approved products include Chenodal®, Cholbam®, and Thiola®, and its pipeline includes compounds for several catastrophic diseases, including focal segmental glomerulosclerosis (FSGS), pantothenate kinase-associated neurodegeneration (PKAN), infantile spasms, nephrotic syndrome and others. For additional information, please visit www.retrophin.com.
Contact: Retrophin, Inc. Chris Cline, CFA Director, Investor Relations 646-564-3680 IR@retrophin.com